NOTE: This is a guest post by our sponsor, Genzyme, A Sanofi Company. They are fully funding and sponsoring the MS Awareness Seminar being organized by the Society for Multiple Sclerosis Patients in Pakistan, scheduled to take place on Saturday 30 May, 2015 at Koh-e-Noor Hall, PC Hotel Lahore, from 4:00 pm – 6:00 pm EVENT DETAILS FDA has approved Genzyme’s AUBAGIO® (teriflunomide), a Once-Daily, Oral Treatment for Relapsing Multiple Sclerosis. U.S. Food and Drug Administration (FDA) has approved AUBAGIO®…